tiprankstipranks
Trending News
More News >

Seres Therapeutics downgraded to Neutral from Buy at Chardan

Chardan downgraded Seres Therapeutics (MCRB) to Neutral from Buy with a $6 price target

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue